BRIEF-GSK files regulatory submissions in U.S. and Europe for lupus drug
September 23, 2016 at 04:44 AM EDT
* GSK announces regulatory submissions for subcutaneous formulation of Benlysta (Belimumab) for patients with systemic lupus disease